Despite the fact that Tp53 null mice are prone to several malignances, it has been reported that 4% develop osteosarcomas (OS showing longer latency than other malignancies) with a higher frequency of OS (25%) in Tp53 heterozygous mice [17,65]. The gene discussed is TP53; the disease is osteosarcoma.